339 related articles for article (PubMed ID: 24974828)
21. Repression of the gene encoding the TGF-beta type II receptor is a major target of the EWS-FLI1 oncoprotein.
Hahm KB; Cho K; Lee C; Im YH; Chang J; Choi SG; Sorensen PH; Thiele CJ; Kim SJ
Nat Genet; 1999 Oct; 23(2):222-7. PubMed ID: 10508522
[TBL] [Abstract][Full Text] [Related]
22. Complex/cryptic
Zou YS; Morsberger L; Hardy M; Ghabrial J; Stinnett V; Murry JB; Long P; Kim A; Pratilas CA; Llosa NJ; Ladle BH; Lemberg KM; Levin AS; Morris CD; Haley L; Gocke CD; Gross JM
Genes (Basel); 2023 May; 14(6):. PubMed ID: 37372318
[TBL] [Abstract][Full Text] [Related]
23. Targeting the CALCB/RAMP1 axis inhibits growth of Ewing sarcoma.
Dallmayer M; Li J; Ohmura S; Alba Rubio R; Baldauf MC; Hölting TLB; Musa J; Knott MML; Stein S; Cidre-Aranaz F; Wehweck FS; Romero-Pérez L; Gerke JS; Orth MF; Marchetto A; Kirchner T; Bach H; Sannino G; Grünewald TGP
Cell Death Dis; 2019 Feb; 10(2):116. PubMed ID: 30741933
[TBL] [Abstract][Full Text] [Related]
24. Expression of ERG, an Ets family transcription factor, identifies ERG-rearranged Ewing sarcoma.
Wang WL; Patel NR; Caragea M; Hogendoorn PC; López-Terrada D; Hornick JL; Lazar AJ
Mod Pathol; 2012 Oct; 25(10):1378-83. PubMed ID: 22766791
[TBL] [Abstract][Full Text] [Related]
25. A novel t(4;22)(q31;q12) produces an EWSR1-SMARCA5 fusion in extraskeletal Ewing sarcoma/primitive neuroectodermal tumor.
Sumegi J; Nishio J; Nelson M; Frayer RW; Perry D; Bridge JA
Mod Pathol; 2011 Mar; 24(3):333-42. PubMed ID: 21113140
[TBL] [Abstract][Full Text] [Related]
26. Ewing sarcoma of the small bowel: a study of seven cases, including one with the uncommonly reported EWSR1-FEV translocation.
Milione M; Gasparini P; Sozzi G; Mazzaferro V; Ferrari A; Casali PG; Perrone F; Tamborini E; Pellegrinelli A; Gherardi G; Arrigoni G; Collini P; Testi A; De Paoli E; Aiello A; Pilotti S; Pelosi G
Histopathology; 2014 Jun; 64(7):1014-26. PubMed ID: 24898918
[TBL] [Abstract][Full Text] [Related]
27. Single-cell RNA profiling identifies diverse cellular responses to EWSR1/FLI1 downregulation in Ewing sarcoma cells.
Khoogar R; Li F; Chen Y; Ignatius M; Lawlor ER; Kitagawa K; Huang TH; Phelps DA; Houghton PJ
Cell Oncol (Dordr); 2022 Feb; 45(1):19-40. PubMed ID: 34997546
[TBL] [Abstract][Full Text] [Related]
28. Development of an Ewing sarcoma cell line with resistance to EWS‑FLI1 inhibitor YK‑4‑279.
Conn E; Hour S; Allegakoen D; Graham G; Petro J; Kouassi-Brou M; Hong SH; Selvanathan S; Çelik H; Toretsky J; Üren A
Mol Med Rep; 2020 Mar; 21(3):1667-1675. PubMed ID: 32016454
[TBL] [Abstract][Full Text] [Related]
29. Malignant round cell tumor of bone with EWSR1-NFATC2 gene fusion.
Sadri N; Barroeta J; Pack SD; Abdullaev Z; Chatterjee B; Puthiyaveettil R; Brooks JS; Barr FG; Zhang PJ
Virchows Arch; 2014 Aug; 465(2):233-9. PubMed ID: 24993903
[TBL] [Abstract][Full Text] [Related]
30. Primary subcutaneous spindle cell Ewing sarcoma with strong S100 expression and EWSR1-FLI1 fusion: a case report.
Arnold MA; Ballester LY; Pack SD; Abdullaev Z; Merchant M; Tsokos MG
Pediatr Dev Pathol; 2014; 17(4):302-7. PubMed ID: 24735198
[TBL] [Abstract][Full Text] [Related]
31. Genome-scale CRISPR-Cas9 screen identifies druggable dependencies in
Stolte B; Iniguez AB; Dharia NV; Robichaud AL; Conway AS; Morgan AM; Alexe G; Schauer NJ; Liu X; Bird GH; Tsherniak A; Vazquez F; Buhrlage SJ; Walensky LD; Stegmaier K
J Exp Med; 2018 Aug; 215(8):2137-2155. PubMed ID: 30045945
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and structure-activity relationship studies of small molecule disruptors of EWS-FLI1 interactions in Ewing's sarcoma.
Tosso PN; Kong Y; Scher L; Cummins R; Schneider J; Rahim S; Holman KT; Toretsky J; Wang K; Üren A; Brown ML
J Med Chem; 2014 Dec; 57(24):10290-303. PubMed ID: 25432018
[TBL] [Abstract][Full Text] [Related]
33. Therapeutic Potential of
Cervera ST; Rodríguez-Martín C; Fernández-Tabanera E; Melero-Fernández de Mera RM; Morin M; Fernández-Peñalver S; Iranzo-Martínez M; Amhih-Cardenas J; García-García L; González-González L; Moreno-Pelayo MA; Alonso J
Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359682
[TBL] [Abstract][Full Text] [Related]
34. The Transcription Factor
García-García L; Fernández-Tabanera E; Cervera ST; Melero-Fernández de Mera RM; Josa S; González-González L; Rodríguez-Martín C; Grünewald TGP; Alonso J
Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830820
[TBL] [Abstract][Full Text] [Related]
35. Lurbinectedin Inactivates the Ewing Sarcoma Oncoprotein EWS-FLI1 by Redistributing It within the Nucleus.
Harlow ML; Maloney N; Roland J; Guillen Navarro MJ; Easton MK; Kitchen-Goosen SM; Boguslawski EA; Madaj ZB; Johnson BK; Bowman MJ; D'Incalci M; Winn ME; Turner L; Hostetter G; Galmarini CM; Aviles PM; Grohar PJ
Cancer Res; 2016 Nov; 76(22):6657-6668. PubMed ID: 27697767
[TBL] [Abstract][Full Text] [Related]
36. Chromosomal localization of Ewing sarcoma EWSR1/FLI1 protein promotes the induction of aneuploidy.
Park H; Kim H; Hassebroek V; Azuma Y; Slawson C; Azuma M
J Biol Chem; 2021; 296():100164. PubMed ID: 33293370
[TBL] [Abstract][Full Text] [Related]
37. Ewing sarcoma.
Grünewald TGP; Cidre-Aranaz F; Surdez D; Tomazou EM; de Álava E; Kovar H; Sorensen PH; Delattre O; Dirksen U
Nat Rev Dis Primers; 2018 Jul; 4(1):5. PubMed ID: 29977059
[TBL] [Abstract][Full Text] [Related]
38. STAG2 mutations alter CTCF-anchored loop extrusion, reduce cis-regulatory interactions and EWSR1-FLI1 activity in Ewing sarcoma.
Surdez D; Zaidi S; Grossetête S; Laud-Duval K; Ferre AS; Mous L; Vourc'h T; Tirode F; Pierron G; Raynal V; Baulande S; Brunet E; Hill V; Delattre O
Cancer Cell; 2021 Jun; 39(6):810-826.e9. PubMed ID: 33930311
[TBL] [Abstract][Full Text] [Related]
39. EWS-FLI1 increases transcription to cause R-loops and block BRCA1 repair in Ewing sarcoma.
Gorthi A; Romero JC; Loranc E; Cao L; Lawrence LA; Goodale E; Iniguez AB; Bernard X; Masamsetti VP; Roston S; Lawlor ER; Toretsky JA; Stegmaier K; Lessnick SL; Chen Y; Bishop AJR
Nature; 2018 Mar; 555(7696):387-391. PubMed ID: 29513652
[TBL] [Abstract][Full Text] [Related]
40. The Ewing Family of Tumors Relies on BCL-2 and BCL-X
Heisey DAR; Lochmann TL; Floros KV; Coon CM; Powell KM; Jacob S; Calbert ML; Ghotra MS; Stein GT; Maves YK; Smith SC; Benes CH; Leverson JD; Souers AJ; Boikos SA; Faber AC
Clin Cancer Res; 2019 Mar; 25(5):1664-1675. PubMed ID: 30348635
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
